As Chief Commercial Officer, Nicholas brings more than 20 years of commercial and launch experience in the fields of virology, cardiovascular and oncology to his role at Shorla Oncology. Over the course of his career, Nicholas has held leadership roles in analytics, market access and commercial operations at pharmaceutical and biotechnology companies. Before joining Shorla Oncology, Nicholas served as Head of Commercial Operations at Oncopeptides, INC. Previously he led Commercial Operations & Market Access at Kempharm and held roles of increasing responsibility at Nextwave Pharmaceuticals, Gilead Sciences & Symphony Health. Nicholas holds a B.A. in Finance from the University of Otago, NZ & B.A. in Architectural Studies from the University of Adelaide, Australia.